Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Boysen

Showing results (71-80 of 252) with videos related to

Pageof 26
Sort By:
Current Opinion in Anaesthesiology|October 3, 2006
Sedation in the critically ill patientJ E Szalados, P G Boysen
Ugeskrift for Laeger|July 22, 1991
[Atrial fibrillation--thromboembolism and prevention]P Petersen, G Boysen, J Godtfredsen
Ochsner Journal|April 6, 2016
Multigenerational Challenges and the Future of Graduate Medical EducationPhilip G Boysen, Laurie Daste, Theresa Northern
Stroke|November 1, 1992
A unified form for neurological scoring of hemispheric stroke with motor impairmentJ M Orgogozo, K Asplund, G Boysen
Missouri Medicine|December 20, 2021
A Dirge for Academic Medicine: Combined Effects of the COVID-19 Pandemic and Private Equity AcquisitionsPhilip G Boysen, Katherine Cox, Gary Hearns
American Journal of Physiology. Heart and Circulatory Physiology|December 6, 2003
Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERKZhelong Xu, Xiang Ji, Philip G Boysen
Ugeskrift for Laeger|October 19, 2000
[Investigation of patients with transient cerebral ischemia]H H Sillesen, G Boysen, B Christensen
Ugeskrift for Laeger|April 26, 1982
[Inhibition of thrombocyte aggregation with small doses of acetylsalicylic acid]G Boysen, J Bøttcher, J S Olsen
Stroke|September 1, 1982
Minimal daily dosage of ASA for platelet inhibitionG Boysen, J Bøttcher, J S Olsen
Ugeskrift for Laeger|May 8, 1995
[Plasma total cholesterol, high density lipoprotein-cholesterol and triglycerides as risk factors for cerebrovascular diseases. A 12-year follow-up by the Osterbro survey]E S Lindenstrøm, G Boysen, J Nyboe
Pageof 26

Showing results (71-80 of 252) with videos related to

Sort By:
Pageof 26
Current Opinion in Anaesthesiology|October 3, 2006
Sedation in the critically ill patientJ E Szalados, P G Boysen
Ugeskrift for Laeger|July 22, 1991
[Atrial fibrillation--thromboembolism and prevention]P Petersen, G Boysen, J Godtfredsen
Ochsner Journal|April 6, 2016
Multigenerational Challenges and the Future of Graduate Medical EducationPhilip G Boysen, Laurie Daste, Theresa Northern
Stroke|November 1, 1992
A unified form for neurological scoring of hemispheric stroke with motor impairmentJ M Orgogozo, K Asplund, G Boysen
Missouri Medicine|December 20, 2021
A Dirge for Academic Medicine: Combined Effects of the COVID-19 Pandemic and Private Equity AcquisitionsPhilip G Boysen, Katherine Cox, Gary Hearns
American Journal of Physiology. Heart and Circulatory Physiology|December 6, 2003
Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERKZhelong Xu, Xiang Ji, Philip G Boysen
Ugeskrift for Laeger|October 19, 2000
[Investigation of patients with transient cerebral ischemia]H H Sillesen, G Boysen, B Christensen
Ugeskrift for Laeger|April 26, 1982
[Inhibition of thrombocyte aggregation with small doses of acetylsalicylic acid]G Boysen, J Bøttcher, J S Olsen
Stroke|September 1, 1982
Minimal daily dosage of ASA for platelet inhibitionG Boysen, J Bøttcher, J S Olsen
Ugeskrift for Laeger|May 8, 1995
[Plasma total cholesterol, high density lipoprotein-cholesterol and triglycerides as risk factors for cerebrovascular diseases. A 12-year follow-up by the Osterbro survey]E S Lindenstrøm, G Boysen, J Nyboe
Pageof 26